US Patent Issued to The Regents of the University of California on July 14 for "Molecular target in cancer" (California Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,681,009, issued on July 14, was assigned to The Regents of the University of California (Oakland, Calif.).

"Molecular target in cancer" was invented by Tannishtha Reya (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods for identifying small molecule modulators of protein-RNA interactions that could potentially function as therapeutic agents in cancer treatment. Methods of identifying inhibitors of the RNA-binding functions of MSI2, as well as inhibitors identified thereof, are also disclosed."

The patent was filed on Jan. 6, 2022, under Application No. 17/647,342.

*For further information, including images, charts a...